AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Imvamune smallpox vaccine clinical study to include eczema patients.
2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug application (IND) for its third-generation smallpox vaccine candidate to enter further clinical trials.
Bavarian Nordic will immediately start a phase l study with Imvamune, its safe third-generation smallpox vaccine, in 60 subjects including persons suffering from atopic dermatitis. This study will be conducted in Europe with the final report expected in 2005.
Persons with atopic dermatitis, more commonly known as eczema, are at
risk in suffering potentially severe side effects from first and second
generation smallpox vaccines.
Peter Wulff, president and chief executive officer said, "With this latest IND, we will initiate, for the first time ever, a trial in a ...
- US Government Grants Additional Award to Bavarian Nordic for Development Of...
- Press release article from: PR Newswire September 25, 2003 700+ words
...generation smallpox vaccine. The award was granted to Bavarian Nordic for meeting...BN as a safe smallpox vaccine. Bavarian Nordic has an extensive...generation smallpox vaccine. In 2002 Bavarian Nordic had a turnover...
- US Government grants additional award to Bavarian Nordic for development of...
- Press release article from: PR Newswire September 25, 2003 700+ words
...generation smallpox vaccine. The award was granted to Bavarian Nordic for meeting...BN as a safe smallpox vaccine. Bavarian Nordic has an extensive...generation smallpox vaccine. In 2002 Bavarian Nordic had a turnover...
- Bavarian Nordic Announces Major Accomplishments in Safe Smallpox Vaccine...
- Press release article from: PR Newswire March 7, 2005 700+ words
...million doses of safe smallpox vaccine. About Bavarian Nordic: Founded in 1994...IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine), and its use...third-generation smallpox vaccine. Bavarian Nordic's advanced clinical...
- Bavarian Nordic Announces Significant Progress in Safe Smallpox Vaccine;...
- Press release article from: PR Newswire August 26, 2004 700+ words
...MVA-BN(R) smallpox vaccine. The US FDA granted Bavarian Nordic an Investigational...IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine). GSK will...doses of MVA smallpox vaccine. Bavarian Nordic will produce...
- Bavarian Nordic Announces Further Investment in Smallpox Vaccine Production and...
- Press release article from: PR Newswire February 22, 2005 700+ words
...IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine), and its...generation smallpox vaccine. Bavarian Nordic's advanced...first-ever smallpox vaccine candidate to...designation. Bavarian Nordic is one of the...
- Bavarian Nordic announces further investment in smallpox vaccine production and...
- Newspaper article from: BIOTECH Patent News February 1, 2005 700+ words
...IMVAMUNE (Bavarian Nordic's smallpox vaccine), and its...generation smallpox vaccine. Bavarian Nordic's advanced...first-ever smallpox vaccine candidate to...designation. Bavarian Nordic is one of the...
- Bavarian Nordic awarded contract to develop smallpox vaccine.
- Newspaper article from: BIOTECH Patent News September 1, 2004 700+ words
...is the second smallpox vaccine development contract awarded to Bavarian Nordic from NIAID...IMVAMUNE (Bavarian Nordic's smallpox vaccine), and its...generation smallpox vaccine. Bavarian Nordic's advanced...
- Bavarian Nordic Awarded a USD 100 Million Contract From US Government to...
- Press release article from: PR Newswire Europe September 30, 2004 700+ words
...is the second smallpox vaccine development contract awarded to Bavarian Nordic from NIAID...IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine), and its...generation smallpox vaccine. Bavarian Nordic's advanced...
Source: HighBeam Research, Imvamune smallpox vaccine clinical study to include eczema patients.